ExploreWatchlistsPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Common stock and paid-in capital

LTT Bio-Pharma Co., Ltd. (E00982)

Market cap
P/E ratio
LTT Biopharma develops new drugs using drug delivery and repositioning technologies, while helping Japanese and Chinese healthcare companies collaborate.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Mar 31, 2025801+0.00%
Mar 31, 2024801+0.00%
Mar 31, 2023801+0.00%
Mar 31, 2022801+0.00%
Mar 31, 2021801+0.00%
Mar 31, 2020801+0.00%
Mar 31, 2019801+0.00%
Mar 31, 2018801+0.00%
Mar 31, 2017801+0.00%
Mar 31, 2016801+0.00%
Mar 31, 2015801

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat